ENAapplication/xmlftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR195/031/SRR19571631/SRR19571631_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR195/027/SRR19571627/SRR19571627_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR195/029/SRR19571629/SRR19571629_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR195/035/SRR19571635/SRR19571635_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR195/033/SRR19571633/SRR19571633_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR195/035/SRR19571635/SRR19571635_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR195/029/SRR19571629/SRR19571629_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR195/026/SRR19571626/SRR19571626_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR195/027/SRR19571627/SRR19571627_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR195/032/SRR19571632/SRR19571632_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR195/030/SRR19571630/SRR19571630_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR195/033/SRR19571633/SRR19571633_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR195/030/SRR19571630/SRR19571630_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR195/034/SRR19571634/SRR19571634_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR195/028/SRR19571628/SRR19571628_1.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR195/034/SRR19571634/SRR19571634_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR195/026/SRR19571626/SRR19571626_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR195/031/SRR19571631/SRR19571631_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR195/032/SRR19571632/SRR19571632_2.fastq.gzftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR195/028/SRR19571628/SRR19571628_2.fastq.gzprimaryOK200GenomicsUniversity of Glasgowhttps://www.ebi.ac.uk/ena/browser/view/PRJNA846693RSV infection in a severely immunocompromised child was treated with a combination of nitazoxanide, ribavirin and favipiravirENAfalseTreatment of RSV infection with ribavirin, nitazoxanide and favipiravir2023-05-192022-06-09PRJNA846693